Quarterly report pursuant to sections 13 or 15(d)

Consolidated Balance Sheets

v2.4.0.8
Consolidated Balance Sheets (USD $)
Mar. 31, 2014
Dec. 31, 2013
Current assets:    
Cash $ 5,410,629 $ 3,610,262
Accounts receivable - net 280,000 270,000
Marketable securities - available for sale securities 6,250 6,250
Prepaid expenses and other current assets 579,382 752,931
Total current assets 6,276,261 4,639,443
Other assets:    
Property and equipment, net 12,223 13,640
Intangible assets, net 5,704,012 6,157,659
Goodwill 2,144,488 2,144,488
Total other assets 7,860,723 8,315,787
Total Assets 14,136,984 12,955,230
Current liabilities:    
Accounts payable and accrued expenses 1,719,242 754,945
Liabilities of discontinued operations 30,664 30,664
Total liabilities 1,749,906 785,609
Stockholders' Equity:    
Preferred stock, $.0001 par value, 50,000,000 shares authorized: none issued and outstanding      
Common stock, ($.0001 par value; 200,000,000 shares authorized; 5,489,593 issued and outstanding at March 31, 2014 and December 31, 2013 549 549
Additional paid-in capital 23,172,350 22,673,287
Accumulated other comprehensive income - marketable securities available for sale (6,250) (6,250)
Accumulated deficits (10,769,075) (10,487,469)
Total Marathon Patent Group, Inc. equity 12,397,574 12,180,117
Non-controlling interest in subsidiary (10,496) (10,496)
Total stockholders' equity 12,387,078 12,169,621
Total liabilities and stockholders' equity $ 14,136,984 $ 12,955,230